Browsing Tag
StablevaX
4 posts
Stablepharma company profile: Business model, pipeline, and growth outlook (2026 edition)
Stablepharma is a UK biotech developing fridge-free vaccines and injectables via its StablevaX platform. Explore its Phase 1 pipeline, AFT Pharmaceuticals partnership, and 2026-2027 growth outlook.
No fridge, no problem: Stablepharma and AFT join forces to make critical drugs shelf-stable
Stablepharma and AFT team up to develop fridge-free cancer and infection drugs. Find out how this could reshape pharma logistics and global access.
Fridge-free vaccine milestone: Stablepharma locks Phase I SPVX02 data in thermostability push
Stablepharma has completed its first human trial for SPVX02, a fridge-free tetanus-diphtheria vaccine designed to work without cold-chain storage. With the data now locked, the company is preparing to scale its thermostable platform for global deployment.
Stablepharma begins world’s first fridge-free vaccine trials; Is the cold chain era ending?
Stablepharma launches the first-ever fridge-free vaccine trial for tetanus and diphtheria—SPVX02—potentially reshaping global vaccine distribution forever.